Semaglutide reduces cardiovascular events in type 2 diabetes: a systematic review and meta-analysis highlighting enhanced benefits in chronic kidney disease
FDA APPROVED DECEMBER 2025 NEW: Oral Wegovy Pricing Major Cost Breakthrough The FDA approved oral Wegovy (semaglutide, the active ingredient) on December 22, 2025the first oral GLP-1 for weight loss
This discovery reaffirmed the belief that even the most basic life forms can be the solution to revolutionary cures.In a breathtaking illustration of the paradoxical position of nature in medicine, deathstalker scorpion venom (Leiurus quinquestriatus) brought about the solution to the treatment of brain tumors
Lemon Vinaigrette: Juice 1 lemon and remove any seeds in a small serving bowl
adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 20032008
Stay informed, make thoughtful choices, and trust 7 Derma Center to support you on your journey to radiance.